Mainolfi Nello Insider Trades

Insider Trading History

Track insider trading activity for Mainolfi Nello. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $49.7M 679,190 shares
Last Trade
Apr 29, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.44M 30,000 shares
$81.18
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $51M 696,195 shares
Last Trade
Apr 29, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.45M 30,000 shares
$81.51
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $15.8M 215,559 shares
Last Trade
Apr 29, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.45M 30,000 shares
$81.51
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $15.7M 215,000 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.4M 215,000 shares
$90.10
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $18M 245,559 shares
Last Trade
Feb 25, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.72M 30,000 shares
$90.68
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $51M 696,195 shares
Last Trade
Feb 25, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.72M 30,000 shares
$90.68
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $49.5M 676,431 shares
Last Trade
Feb 25, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.71M 30,000 shares
$90.25
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $48.8M 666,195 shares
Last Trade
Jan 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$226k 3,118 shares
$72.41
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $32.7M 446,882 shares
Last Trade
Jan 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$226k 3,118 shares
$72.41
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $49M 669,091 shares
Last Trade
Dec 31, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.34M 30,000 shares
$78.06
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $50.7M 693,077 shares
Last Trade
Dec 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.33M 30,000 shares
$77.81
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $20.2M 275,559 shares
Last Trade
Dec 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.33M 30,000 shares
$77.81
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $20M 272,505 shares
Last Trade
Dec 17, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$213k 2,595 shares
$82.07
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $48.5M 663,077 shares
Last Trade
Dec 17, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$213k 2,595 shares
$82.07
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $22.4M 305,559 shares
Last Trade
Dec 08, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.66M 100,000 shares
$66.62
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $48.4M 660,482 shares
Last Trade
Dec 08, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.66M 100,000 shares
$66.62
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $55.7M 760,482 shares
Last Trade
Dec 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.66M 100,000 shares
$66.62
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $50.4M 688,620 shares
Last Trade
Oct 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.83M 30,000 shares
$60.99
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $50.6M 690,482 shares
Last Trade
Oct 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.8M 30,000 shares
$60.03
$73.21
Kymera Therapeutics
Kymera Therapeutics KYMR
Chief Executive Officer
Holding Value $29.7M 405,559 shares
Last Trade
Oct 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.8M 30,000 shares
$60.03
$73.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up